Nanoform Finland OYJ Logo

Nanoform Finland OYJ

Offers nanoparticle engineering services to enhance drug performance for pharma clients.

NANOFH | ST

Overview

Corporate Details

ISIN(s):
FI4000330972
LEI:
743700JJO2NU8LBS1592
Country:
Finland
Address:
Viikinkaari 4, FI-00790 HELSINKI

Description

Nanoform is a nanoparticle medicine enabling company that provides expert services in drug particle engineering to the global pharmaceutical and biotech industries. The company utilizes its proprietary, scalable Controlled Expansion of Supercritical Solutions (CESS®) technology to enhance the performance of both small and large molecule therapeutics. By creating uniform nanoparticles, Nanoform's services aim to improve drug bioavailability and solubility, enable higher drug loading in smaller dosage forms, and facilitate novel delivery routes such as subcutaneous, long-acting injectable, and inhaled formulations. The company partners with clients throughout the drug development lifecycle to overcome formulation challenges and reduce clinical trial attrition.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Nanoform Finland OYJ filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Nanoform Finland OYJ

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Nanoform Finland OYJ via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Hana Pharm. Co., Ltd. Logo
A pharmaceutical company specializing in anesthetics and narcotic analgesics.
South Korea
293480
HANDOK Inc. Logo
Develops, manufactures, and distributes drugs, medical devices, and diagnostics.
South Korea
002390
Hanmi Pharm. Co., Ltd. Logo
A research-oriented biopharmaceutical company developing and manufacturing therapies.
South Korea
128940
Hanmi Science Co.,Ltd Logo
A holding company managing subsidiaries in the pharmaceutical and healthcare sectors.
South Korea
008930
Hansa Biopharma Logo
Develops antibody-cleaving enzyme technology for rare immunologic diseases.
Sweden
HNSA
Harmony Biosciences Holdings, Inc. Logo
Develops and commercializes therapies for rare neurological diseases.
United States of America
HRMY
HARROW, INC. Logo
An eyecare pharmaceutical company that develops and commercializes ophthalmic products.
United States of America
HROW
HCW Biologics Inc. Logo
Develops immunotherapies for diseases linked to aging and chronic inflammation.
United States of America
HCWB
Heidelberg Pharma AG Logo
Clinical-stage biopharma developing Amanitin-based ADCs for targeted cancer therapies.
Germany
HPHA
Helixmith Co., Ltd Logo
A biotechnology company specializing in the research and development of gene therapies.
South Korea
084990

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.